Catherine S. Diefenbach, Opeyemi Jegede, Victoria Wang, Stephen M. Ansell, Lale Kostakoglu, Christian Steidl, Yasodha Natkunam, David W. Scott, Richard F. Ambinder, Kevin A. David, Ranjana H. Advani, Nancy L. Bartlett, Michael A. Roberston, Sachdev P. Thomas, Jonathon Cohen, Sami Ibrahimi, Gaurav Goyal, Neha Mehta-Shah, Jennifer E. Amengual, Christopher J. Forlenza, Peter D. Cole, Fenghai Duan, Kara Kelly, Brad S. Kahl. "A randomized phase 2 study of ipilimumab, nivolumab, and brentuximab vedotin in patients with relapsed Hodgkin lymphoma." Blood, 2026. doi:10.1182/blood.2025029546